Home / Executive Moves / Thomas D’Agostino Joins Fluor as Govt Group Strategic Planning, Development SVP

Thomas D’Agostino Joins Fluor as Govt Group Strategic Planning, Development SVP

Thomas D'Agostino
Thomas D’Agostino

Thomas D’Agostino, former administrator of the National Nuclear Security Administration, has joined Fluor Corp.’s (NYSE: FLR) government group as senior vice president of strategic planning and development.

The 36-year government service veteran retired from NNSA in January after six years as its chief, Fluor said Thursday.

News of his appointment comes in the same week the company announced Bill Bodie as senior vice president of business development for the government group (click here to read our previous coverage).

Prior to becoming administrator, D’Agostino served as the agency’s deputy administrator for defense programs, where directed the Stockpile Stewardship Program, including three national research laboratories, four production plants and the Nevada National Security Site.

He also worked to help the Energy Department start up its tritium production reactors and served as program manager for the Naval Sea Systems Command’s SEAWOLF submarine propulsion system.

D’Agostino is also a former Naval Reserve captain and also served eight years on active duty as a naval submarine officer.

While on active duty, he served as a staff member for the Navy inspector general and the deputy chief of naval operations for submarine warfare.

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.